Hydrostasis Named as One of SOSV's Human Health Top 100 for 2023
April 2023

SAN DIEGO, April 2023 -- Hydrostasis is honored to be recognized for the second year in a row on the SOSV Human Health 100, a list celebrating the top 100 health-focused companies within SOSV’s global portfolio of more than 1,000 startups.

SOSV, a leading global venture capital firm, created the Human Health 100 to spotlight the most promising companies advancing human health across a broad range of sectors: including cancer therapeutics, CRISPR diagnostics, assistive robotics, and remote healthcare. Companies are selected based on both current traction and future potential.

Hydrostasis' continued inclusion reflects our dedication to advancing personalized hydration monitoring through real-time sensing technology and intelligent algorithms, empowering better health outcomes for athletes, older adults, and individuals managing chronic conditions. We’re proud to stand once again alongside visionary startups shaping the future of human health.

View the full Human Health 100 list for 2023 here: https://sosv.com/the-2023-sosv-human-health-100/

More from our blog
A Surreal Moment at CES 2026
CES has a way of compressing years of work into a single moment.
Hydrostasis Heads to CES 2026
Hydrostasis is kicking off the new year at CES 2026
GECA Watch 2.0 Is Live
We just went live with GECA Watch 2.0.
Inside Our IV Hydration Research Study with GECA Watch 2.0
A few weeks ago, we completed a hands-on research study with ASAP IVs, putting GECA Watch 2.0 to the test in a real clinical setting.
Taking GECA Watch 2.0 Into the Real World
This past weekend, we took GECA Watch 2.0 out of the lab and into the real world during a research study hosted at ASAP IVs
A Sneak Peek at GECA Watch 2.0: San Diego Event Recap
This past weekend, we opened the doors in Encinitas for a first look at GECA Watch 2.0, and San Diego showed up.